Medicina Basada En Evidencia

Table of contents

Introduction 1
Background 1
Description 1
Scope 1
Audience 2
Summary 2
Grey Literature Checklist 3
Health Technology Assessment (HTA) Agencies 3
Canada 3
International 5
Australia 6
Austria 7
Belgium 7
Denmark 7
Finland 7
France 8
Germany 8
Ireland 8
The Netherlands 8
New Zealand 9
Norway 9
Spain 9
Sweden 9Switzerland 10
UK 10
US 11
Health Economics 13
Canada 13
International 13
Clinical Practice Guidelines 15
Canada 15
International 15
Drug and Device Regulatory Approvals 17
Canada 17
International 18
Advisories and Warnings 19
Canada 19
International 20
Drug Class Reviews 21
Clinical Trials (Ongoing) 22
Canadian Drug Formularies 24
General 24
Provincial 24Databases (free) 26
Statistics 29
Canada 29
US 30
International 30
Miscellaneous 31
Internet Search 31
Open Access Journals 31
Ethics 32

Introduction


Background

The Canadian Agency for Drugs and Technologies in Health (CADTH) provides Canada’s federal, provincial, and territorial health care decision makers with credible, impartial advice and evidence-basedinformation about the effectiveness and efficiency of drugs and other health technologies. To achieve its mandate, CADTH produces a variety of publications that range from comprehensive systematic reviews and economic evaluations to more concise bulletins and updates.

In order to search for and retrieve the evidence base required to produce CADTH reports, the Information Services team has developed agrey literature checklist. Grey literature includes reports and government information that are not published commercially and that are inaccessible via bibliographic databases. The checklist is used to:
• ensure the retrieval of all relevant health technology assessment (HTA), government, and evidence-based agency reports that may not be indexed in bibliographic databases such as MEDLINE
• helpdocument the grey literature search process, thereby increasing transparency and the potential for reproducibility
• ensure that grey literature searching is done in a standardized and comprehensive way.


Description

This checklist includes national and international HTA web sites, drug and device regulatory agencies, clinical trial registries, health economics resources, Canadian healthprevalence or incidence databases, and drug formulary web sites.

Organized by topic, the checklist includes tips on navigating the web sites. Although the web sites are usually assigned to only one category, in many cases an individual web site may have relevancy in additional categories. The checklist does not supply background information on the agencies. If available, however, the name ofthe web site is a hyperlink to a brief description of the agency.

This checklist is meant to be used to document all aspects of the search process. This includes the documentation of all keywords used in the search and information about the availability of each web site as well as the use of a drop-down box beside each web site to indicate the success or relevancy of the retrieval.


ScopeThe CADTH grey literature checklist is not exhaustive, but it does strive to be comprehensive regarding Canadian and international HTA agencies. To compensate for the focused characteristics of the checklist, supplemental keyword searches on two search engines are part of the process.

Commercial bibliographic databases, such as MEDLINE, EMBASE, and The Cochrane Library, are also searched forCADTH reports. Because this checklist focuses on grey literature, these bibliographic databases are not listed here (although we have included a few free databases that contain commercially published literature; for example, PubMed).

This publication is provided only online because it is a tool for evidence-based searching on the Internet. The checklist is updated regularly to reflect changes...